Buprenorphin/Naloxon "Mylan" 8+2 mg resoribletter, sublinguale Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

buprenorphin/naloxon "mylan" 8+2 mg resoribletter, sublinguale

mylan ab - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg

Libroxar 2+0,5 mg resoribletter, sublinguale Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

libroxar 2+0,5 mg resoribletter, sublinguale

laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 2+0,5 mg

Libroxar 8+2 mg resoribletter, sublinguale Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

libroxar 8+2 mg resoribletter, sublinguale

laboratoires smb s.a. - buprenorphinhydrochlorid, naloxonhydrochloriddihydrat - resoribletter, sublinguale - 8+2 mg

Fampridine Accord Den Europæiske Union - dansk - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - multipel sclerose - andre narkotika stoffer - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).